LIKE many cancers, ovarian cancer has long been known as a ‘silent’ disease. This is because its symptoms tend to be vague, ...

The comparable rates of remission pre- and post-pandemic suggest that COVID-19 did not negatively impact the outcomes of ...

Research into improving the detection of ovarian cancer is set to get a boost thanks to funding from the Cancer Society. Two ...

The World Ovarian Cancer Coalition (the Coalition) announced today the publication of a first-of-its-kind study that reveals ...

Clinical trials of a simple and accurate blood test to detect early-stage ovarian cancer – key to boosting survival rates – ...

Research into improving the detection of ovarian cancer is set to get a boost thanks to funding from the Cancer Society.

Ovarian cancer is one of the deadliest gynaecological cancers, yet there currently is no early diagnostic test. Here’s what you need to know.

Clinical trials of a simple and accurate blood test to detect early-stage ovarian cancer - key to boosting survival rates - ...

Screening for risk factors of ovarian cancer using artificial intelligence, UniSA researchers found that the oral ...

Queensland women are to take part in groundbreaking clinical trials for a blood test that will detect early stage ovarian cancer.

Results from OVATION 2 Study continue to validate TheraPlas® technology, demonstrating DNA-mediated production of key anti-cancer immune cytokines following treatment IMNN-001 continues to show ...